Genetic Vaccines and Therapy
暂无分享,去创建一个
H. Rammensee | J. Probst | G. Jung | S. Pascolo | B. Scheel | I. Hoerr | Sonja Brechtel
[1] H. Rammensee,et al. Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines , 2004, Cellular and Molecular Life Sciences CMLS.
[2] S. Pascolo. Messenger RNA-based vaccines , 2004, Expert opinion on biological therapy.
[3] D. Weissman,et al. mRNA Is an Endogenous Ligand for Toll-like Receptor 3* , 2004, Journal of Biological Chemistry.
[4] S. Grupp,et al. RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy. , 2004, Blood.
[5] Shizuo Akira,et al. Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.
[6] S. Akira,et al. Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.
[7] H. Rammensee,et al. Immunostimulating capacities of stabilized RNA molecules , 2004, European journal of immunology.
[8] D. Klinman,et al. DNA vaccines: safety and efficacy issues , 2004, Springer Seminars in Immunopathology.
[9] M. Dewhirst,et al. Synergy between tumor immunotherapy and antiangiogenic therapy. , 2003, Blood.
[10] J. Ulmer,et al. Technical and regulatory hurdles for DNA vaccines. , 2003, International journal for parasitology.
[11] Jeffrey I. Gordon,et al. Angiogenins: a new class of microbicidal proteins involved in innate immunity , 2003, Nature Immunology.
[12] J. Schröder,et al. RNase 7, a Novel Innate Immune Defense Antimicrobial Protein of Healthy Human Skin* , 2002, The Journal of Biological Chemistry.
[13] C. van Broeckhoven,et al. Messenger RNA Electroporation of Human Monocytes, Followed by Rapid In Vitro Differentiation, Leads to Highly Stimulatory Antigen-Loaded Mature Dendritic Cells1 , 2002, The Journal of Immunology.
[14] J. Tazi,et al. mRNA degradation machines in eukaryotic cells. , 2002, Biochimie.
[15] G. Wilson,et al. Ribonuclease Inhibitor from Human Placenta , 2002 .
[16] M. Deutscher,et al. Exoribonuclease superfamilies: structural analysis and phylogenetic distribution. , 2001, Nucleic acids research.
[17] R. Granstein,et al. Induction of anti-tumor immunity with epidermal cells pulsed with tumor-derived RNA or intradermal administration of RNA. , 2000, The Journal of investigative dermatology.
[18] H. Rammensee,et al. In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. , 2000, European journal of immunology.
[19] Y. Kaneda,et al. RNA melanoma vaccine: induction of antitumor immunity by human glycoprotein 100 mRNA immunization. , 1999, Human gene therapy.
[20] H. Rosenberg,et al. Eosinophils, ribonucleases and host defense: Solving the puzzle , 1999, Immunologic research.
[21] S. Sorrentino. Human extracellular ribonucleases: multiplicity, molecular diversity and catalytic properties of the major RNase types , 1998, Cellular and Molecular Life Sciences CMLS.
[22] A. Vlassov. Human ribonucleases. , 1998, Biochemistry. Biokhimiia.
[23] D. J. Strydom. The angiogenins , 1998, Cellular and Molecular Life Sciences CMLS.
[24] M. Seno,et al. Tissue-specific expression of pancreatic-type RNases and RNase inhibitor in humans. , 1997, DNA and cell biology.
[25] E. Gilboa,et al. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo , 1996, The Journal of experimental medicine.
[26] N. Yang,et al. Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization. , 1996, Gene therapy.
[27] D. Curiel,et al. Characterization of a messenger RNA polynucleotide vaccine vector. , 1995, Cancer research.
[28] G. Lenzen,et al. Induction of virus‐specific cytotoxic T lymphocytes in vivo by liposome‐entrapped mRNA , 1993, European journal of immunology.
[29] D. Williams,et al. 2'-Fluoro- and 2'-amino-2'-deoxynucleoside 5'-triphosphates as substrates for T7 RNA polymerase. , 1992, Biochemistry.
[30] G. Acsadi,et al. Direct gene transfer into mouse muscle in vivo. , 1990, Science.
[31] S. Benner. Extracellular ‘communicator RNA’ , 1988, FEBS letters.
[32] J F Riordan,et al. Amino acid sequence of human tumor derived angiogenin. , 1985, Biochemistry.
[33] A Blank,et al. Ribonucleases of human serum, urine, cerebrospinal fluid, and leukocytes. Activity staining following electrophoresis in sodium dodecyl sulfate-polyacrylamide gels. , 1981, Biochemistry.
[34] M. Mardiney,et al. Alteration of human serum ribonuclease activity in malignancy. , 1978, CRC critical reviews in clinical laboratory sciences.
[35] I. Freedberg,et al. III. THE RIBONUCLEASES OF HUMAN EPIDERMIS , 1977 .
[36] S. Moore,et al. Ribonuclease inhibitor from human placenta. Purification and properties. , 1977, The Journal of biological chemistry.
[37] I. Freedberg,et al. Epidermal nucleases. II. The multiplicity of ribonucleases in guinea-pig epidermis. , 1977, The Journal of investigative dermatology.
[38] J. Holcenberg,et al. Enzymes as drugs. , 1977, Annual review of pharmacology and toxicology.
[39] S. W. Melbye,et al. Epidermal nucleases. III. The ribonucleases of human epidermis. , 1977, The British journal of dermatology.
[40] A. Goldstein,et al. Purification and properties , 1975 .
[41] F. Eckstein,et al. Nucleoside phosphorothioates. , 1970, Journal of the American Chemical Society.
[42] V. Winter,et al. Demonstration of ribonuclease and desoxyribonuclease in human skin by means of fluorescent antibodies. , 1969, The Journal of investigative dermatology.
[43] A. Jarrett. Acid nucleases in human skin. , 1967, The Journal of investigative dermatology.
[44] G. Steigleder,et al. The localization of ribonuclease and deoxyribonuclease activities in normal and psoriatic epidermis. , 1962, The Journal of investigative dermatology.
[45] R. W. Holley,et al. Evidence for the liberation of a nuclease from human fingers. , 1961, The Journal of biological chemistry.
[46] J. Tabachnick,et al. Demonstration of Nucleases on Mammalian Skin Surface and in Saline Extracts of Hair , 1961, Nature.